If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Patient Advocacy
Download FREE Excerpt
19 Info Graphics
9 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
As part of this evolution, Medical Affairs groups have been charged with patient engagement, bringing together caregivers, payers, healthcare professionals, and patient advocacy groups in a comprehensive environment centering on patients’ needs.
This Best Practices, LLC study informs medical leaders by benchmarking best practices in Medical Affairs’ role in patient engagement activities. Specifically, this study examines Medical Affairs’ role and responsibilities in patient engagement activities such as patient outcomes, advocacy, education and adherence.
Best Practices, LLC engaged 39 leaders from 29 biopharmaceutical companies through a benchmarking survey.
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care
Abbvie; Clovis Oncology; Actelion; TG Therapeutics; Alkermes; Vifor Pharma; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; cipla; Daiichi Pharmaceutical Co.; Ltd.; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; MSD; Novartis; Pfizer; Roche; Sanofi Pasteur; Santen; Shire; Sunovion; Teva Pharmaceutical Industries Ltd; Theravance; Tocagen; UCB Pharma